Johnson & Johnson (JNJ) Shareholder's Equity Growth (1y) (2010 - 2026)

Johnson & Johnson (JNJ) Shareholder's Equity Growth (1y) (2010 - 2026) Analysis & Trends

Generated on {Timestamp} © BusinessQuant.com
Generated on {Timestamp} Powered by BusinessQuant Logo

Peer Comparison

# Company Market Cap Enterprise Value Gross Profit (Qtr)
1 Gsk 93,699,046.73 Bn 93,699,041.77 Bn 7.76 Bn
2 Eli Lilly 1,012.06 Bn 1,006.77 Bn 16.22 Bn
3 Johnson & Johnson 560.67 Bn 538.62 Bn 15.96 Bn
4 AbbVie 402.20 Bn 392.85 Bn 10.78 Bn
5 Merck 298.59 Bn 292.94 Bn 12.09 Bn
6 Amgen 188.77 Bn 176.74 Bn 5.87 Bn
7 Gilead Sciences 160.22 Bn 152.49 Bn 5.52 Bn
8 Pfizer 148.19 Bn 135.42 Bn -1.21 Bn
9 Bristol Myers Squibb 116.72 Bn 106.26 Bn 8.07 Bn
10 Novartis Ag 109.78 Bn 109.09 Bn -

Historic Data

Download Data
DateValue
Mar 29, 2026 3.94%
Dec 28, 2025 14.06%
Sep 28, 2025 13.00%
Jun 29, 2025 9.69%
Mar 30, 2025 11.55%
Dec 29, 2024 3.95%
Sep 29, 2024 -1.50%
Jun 30, 2024 -6.37%
Mar 31, 2024 -1.20%
Dec 31, 2023 -10.46%
Oct 1, 2023 -4.52%
Jul 2, 2023 0.07%
Apr 2, 2023 -5.14%
Jan 1, 2023 3.76%
Oct 2, 2022 6.16%
Jul 3, 2022 9.74%
Apr 3, 2022 13.48%
Jan 2, 2022 16.98%
Oct 3, 2021 8.99%
Jul 4, 2021 10.48%